Barinthus Biotherapeutics Plc (BRNS)
0.6807
0.00 (0.00%)
USD |
NASDAQ |
Jun 01, 16:00
Barinthus Biotherapeutics Total Liabilities (Quarterly) : 25.66M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Kiniksa Pharmaceuticals International Plc | 219.59M |
| Autolus Therapeutics Plc | 418.24M |
| Scancell Holdings Plc | -- |
| OptiBiotix Health Plc | -- |
| Adaptimmune Therapeutics Plc | 201.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 92.14M |
| Shareholders Equity (Quarterly) | 66.40M |
| Debt to Equity Ratio | 0.1658 |
| Current Ratio | 6.055 |
| Net Debt Paydown Yield | 0.86% |